Thursday, September 10, 2009

Investors Announced: Rocky Mountain Life Science Investor Conference

On Thursday, September 17, Denver will welcome 31 life science investors and business development professionals for the inaugural Rocky Mountain Life Science Investor Conference. The conference will showcase 30 of the region’s top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.

“We are excited to welcome over 30 of the life science community’s most renowned investors to the inaugural Rocky Mountain Life Science Investor Conference,” said John Collar, President and CEO of the Colorado BioScience Association. “This will allow Colorado and the Rocky Mountain region to offer an inside look into the innovation and talent that lies in this region, and we can’t wait to see the partnerships and connections made during this conference.”The 31 Investor firms and companies attending to date for the September 17 Conference include:
o Boulder Ventures,
o Celgene,
o Chart Life Scienceso Clovis Oncology
o Covidien,
o Frazier Healthcare Ventures,
o Genentech,
o H.I.G. Ventures,
o High Country Ventures,
o Hunt BioVentures,
o Johnson & Johnson,
o Keld, LLC,
o KRG Capital Partners,
o Lilly Ventures,
o Mesa Verde Venture Partners,
o Morgenthaler Ventures,
o NovaQuesto Novartis Venture Fund,
o Prairiegold Ventures,
o Puente Partnerso Red Script,
o Rocky Mountain Venture Capital Association,
o Sequel Ventures,
o Skyline Ventures,
o Sun Mountain Capital,
o Technology Partners,
o Telegraph Hill Partners,
o vSpring Capital,
o Yasuda Enterprise Development,

No comments:

Post a Comment